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Abstract 
Currently, porcine reproductive and respiratory syndrome virus (PRRSV) 
is the most economically significant disease affecting the swine industry.  PRRSV 
is known for its restricted cell tropism, primarily infecting porcine alveolar 
macrophages (PAM) via receptor-mediated endocytosis.  PRRSV infects only a 
portion of the PAM population both in vivo and in vitro, which suggests that not 
every macrophage is PRRSV-permissive. Three surface proteins that can act as 
receptors for PRRSV have been identified on PAM, however, little else is known 
about the regulation of macrophage tropism.  Factors determining cellular 
permissibility or resistance to PRRSV infection remain largely uncharacterized, 
although a recent study from our laboratory demonstrated that 1) permissiveness 
to PRRSV infection increased with time in culture, 2) macrophages from infected 
pigs could be superinfected, and 3) addition of actinomycin D, which inhibits 
mRNA synthesis, blocked infection.  These data suggest that a PRRSV-
permissive subpopulation of cells derives from a non-permissive precursor 
population and depends on new mRNA synthesis.  The current studies were 
designed to examine the effects of PRRSV on both infected and uninfected PAM 
cells in vitro, specifically focusing on the expression of MHC I, MHC II, CD14, 
CD163 and CD172a surface proteins.  The results show upregulation of MHC II, 
CD14, CD163 and CD172a expression in PRRSV-infected cells and a 
downregulation on the uninfected cells within the PRRSV-inoculated cultures.  
The role of apoptosis in the PRRSV-inoculated cultures was investigated, with 
results showing similar, low levels of apoptosis in control and infected PAM. 
PAM cytokine responses to PRRSV and LPS were also examined and, although 
they were uniquely different relative to control PAM, no trends were detected in 
the responses of PAM infected with PRRSV compared to uninfected and 
classically stimulated PAM.  These data confirm that there are at least two subsets 
of macrophages within the alveolar population and suggests that the subsets are 
differentially affected by PRRS virus.    We also demonstrated that MHC I 
  
becomes undetectable on PAM as a result of the freezing process, and that 
PRRSV-permissiveness is greater in the cell population after freezing.   
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 CHAPTER 1 - Porcine Reproductive and Respiratory Syndrome 
Virus Literature Review 
Introduction 
Porcine reproductive and respiratory syndrome virus (PRRSV), one of the most important 
infectious agents of swine, is endemic in the world’s largest pork producing nations and accounts 
for massive global economic losses each year.  PRRSV is very infectious and capable of 
transmission through many routes, causing reproductive failure in pregnant sows and respiratory 
disease and mortality in young pigs.  Although it is difficult to assess the cost of PRRS to the 
industry, estimates currently approximate losses of $600 million in the United States each year.  
One reason control of PRRSV has been difficult is that the mechanisms by which PRRSV evades 
host immune responses are poorly understood.  Therefore, the purpose of this work was to 
examine the effects of PRRSV on one of its principal target cells, the alveolar macrophage.   
PRRSV 
History 
Outbreaks of a new disease began occurring in swine in the United States and Western 
Europe at approximately the same time in the late 1980’s.  The syndrome, which caused 
reproductive failure in pregnant sows and respiratory disease in young pigs (7, 21), was initially 
given several different names, including: mystery swine disease, blue-eared pig disease, porcine 
epidemic abortion and respiratory syndrome (PEARS) and swine infertility and respiratory 
syndrome (SIRS) (67).  Within a few years the disease, now commonly referred to as Porcine 
Reproductive and Respiratory Syndrome (PRRS), had become endemic in the world’s largest 
swine producing countries of North and South America, Europe, and Asia, and continues to 
result in substantial annual economic losses in those countries today.  Etiology 
The etiologic agent, PRRSV, was isolated in 1991 in the U.S. and the Netherlands (7, 21, 
108).  PRRSV is a enveloped, single-stranded positive-sense RNA virus with an approximately 
15 kb genome containing nine open reading frames (23).  The envelope surrounds the RNA and 
N protein capsid and consists of six structural proteins: the two major membrane proteins, 
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 glycoprotein (GP) 5 and matrix protein (M), and minor structural proteins GP2a, GP3, GP4, 
envelope protein (E) (23, 85).  ORFs 1a and 1b code for non-structural viral replicase proteins, 
ORFs 2a/b, 3, 4, and 5 and 6 encode structural membrane proteins and ORF7 codes for the 
nucleocapsid (N) proteins (101, 114). 
PRRSV belongs to the Arteriviridae family, which is grouped together with the 
Coronaviridae and Roniviridae families to form the order Nidovirales.  Other arteriviruses 
include lactate dehydrogenase-elevating virus (LDV) in mice, simian hemorrhagic fever virus 
(SHFV) and equine arteritis virus (EAV) (12), all of which are characterized by persistent 
infections in the presence of an active host immune response and replication in cells of the 
monocyte lineage (5, 18).  The European PRRSV strain, originally referred to as the Lelystad 
virus, is representative of genotype 1 viruses (106). VR-2233 isolated in North America, is 
representative of genotype 2 viruses (7, 21). Although type 1 and type 2 (North American) PRRS 
viruses share similar morphological and biochemical properties, they share only about 67% 
nucleotide identity at the genomic level and are antigenically distinct. 
Cell Tropism  
Both in vivo and in vitro evidence suggests that, while cells of the monocyte/macrophage 
lineage are the primary targets for PRRSV, only small subpopulations of these cells are actually 
permissive to PRRSV infection (16, 34).  In vitro, several cell types have been determined to be 
PRRSV-permissive and to propagate viral replication.  Besides primary porcine alveolar 
macrophage (PAM) cell cultures, cultivated primary peripheral blood monocytes (PBMC), 
monocyte-derived dendritic cells (mo-DC), and the African green monkey kidney cell line MA-
104 and cells derived therefrom, such as MARC-145 and CL-2621, have been demonstrated to 
sustain productive viral replication (34, 45, 55, 90, 107).   
PRRSV enters cells via receptor-mediated endocytosis, which is thought to be initiated 
through viral attachment to cellular receptors and/or coreceptors (49, 65).  At present, three 
potential PRRSV receptors have been identified on PAM:  heparin sulfate, sialoadhesin and 
CD163 (11, 28, 29, 104).  In contrast, sialoadhesin is not expressed on the cell surface of 
MARC-145 cells (44, 113), although two different cellular proteins, CD151 and simian vimentin, 
have been identified as possible PRRSV-receptors (46, 86).  Thus, depending on the cell type 
there might be as many as five different receptors for PRRSV entry.  Additional cofactors 
involved in susceptibility to PRRSV may be involved in viral attachment an entry.   
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 Transmission 
Horizontal PRRSV transmission results when susceptible animals, naïve for a specific 
PRRSV strain, have contact with infected animals. PRRSV has been isolated in porcine blood, 
saliva, feces, milk and colostrum (106, 112), and can be acquired through the oral-nasal route.  
Semen from infected boar studs has been demonstrated to contain virus for up to 92 d.p.i. (19), 
and is also a common direct route for PRRSV transmission (20).  In addition, it has recently been 
demonstrated that pigs can acquire PRRSV through breaks in the skin barrier (41).  While 
normal pig behavior is sufficient to result in cuts and scrapes, standard management practices 
including vaccination, ear notching/tagging, tooth clipping and tail docking may create 
additional routes for PRRSV entry (41).  Vertical transmission of PRRSV occurs when pregnant 
sows and gilts acquire infection during mid to late gestation (17). 
PRRSV is highly infectious, and in addition to transmission through direct contact, can 
be spread by many indirect routes.  Fomites, such as boots, coveralls, coolers/containers (71), 
and transport vehicles (24, 26) can carry virus to new locations and cause infections in naïve 
pigs.  Insects, specifically mosquitoes (Aedes vexans) and houseflies (Musca domestica) found 
commonly during the summer months in swine facilities, can also to function as mechanical 
vectors of PRRSV (71, 73).  Insects are thought to function strictly in transport of PRRSV, 
however, and there has been no documentation of insects serving as biological vectors (72, 85).  
Rodents, raccoons, opossums, skunks, starlings, sparrows, dogs and cats have all been eliminated 
as potential biological and mechanical vectors (111) although it is yet undetermined if migratory 
waterfowl facilitate PRRSV spread (78, 117).  Finally, it has been proposed that aerosol 
transmission of PRRSV may occur both between farms and within pig populations, although 
conclusive evidence is lacking and the issue remains unresolved (71, 78).   
PRRSV Infection 
Pathology 
PRRS is characterized by reproductive and respiratory signs, and the severity is 
dependent upon several factors, including: pathogenicity of the viral strain, reproductive status of 
the infected animal, and age at time of infection (77, 96).  In the respiratory form of PRRS, 
young animals exhibit the most severe pathology and respiratory disease, which is often 
accompanied by secondary infections (95, 96, 111).  During acute PRRS, the virus can be 
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 isolated from most organs and tissues. Later, the virus disappears from the serum and organs, 
except for continued replication in tonsils, lungs and lymph nodes (5, 77, 110).  Adult pigs may 
also be susceptible to PRRSV-infection.  In non-pregnant animals PRRS is typically nonfatal and 
results in transient flu-like symptoms, including mild fever and inappetance (87).  When 
pregnant gilts and sows become  infected during mid- to late-gestation, however, clinical signs 
are primarily reproductive and include late-term abortions, mummified fetuses, premature 
farrowing, stillbirths and weak neonates exhibiting high mortality and severe respiratory disease 
(7, 21).   
While strain pathogenicity differences can greatly affect the level of viral replication 
within a host, differences between individual pigs can also affect both the susceptibility and 
immune response of an animal to PRRSV infection.  For example, individual susceptibilities to 
PRRSV infection have been demonstrated to have a genetic association, although the exact 
correlation has yet to be determined (1, 2, 86, 105).  Also, health status of an animal may affect 
PRRSV disease intensity, as several studies demonstrate that concurrent infections with 
organisms such as porcine circovirus type 2 (PCV2) and Mycoplasma hyopneumoniae result in 
intensified disease and pathology (13, 80).   
Persistence 
The prolonged period of asymptomatic viral shedding and replication is a hallmark of 
PRRSV infection, and is generally referred to as a period of chronic viral persistence because of 
its extended duration compared to typical viral respiratory infections (37).  Several studies have 
examined the duration of PRRSV persistence in pig tissues, but the results are variable, likely the 
result of differences in pathogenicity of the PRRSV strain used and animal susceptibility (34, 50, 
77, 112).  PRRSV has been recovered from infected swine populations up to 105 days post-
inoculation (d.p.i.) (42), from individual animals 225 d.p.i. (4, 110), and from the serum of 
congenitally infected animals at 210 days post-farrowing (15).  Analysis of tissues in PRRSV-
infected animals has identified the thymus, tonsil, and male reproductive organs as the locations 
of PRRSV replication during the persistent stage of infection (5, 20, 79, 112).  Although 
intensive research efforts have been focused on PRRSV since its emergence, the mechanism by 
which the virus evades host immune responses is unknown (5, 110) and persistent infection 
remains a principal contributing factor in the world-wide spread of PRRSV. 
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 Cellular and Humoral Immune Responses  
Various features of the porcine immune response to PRRSV infection have been 
characterized as atypical.  For instance, a PRRSV-specific humoral response can be detected at 
approximately 5-7 d.p.i., however it consists primarily of a non-neutralizing antibody response 
(23, 50, 116) that lacks the capability to induce complement-mediated lysis of infected cells (22).  
Studies suggest that these antibodies differ from the normal repertoire in that they are 
polyclonally activated, containing non-mutated germline configurations in their heavy-chain 
variable regions (10).  At approximately 4 weeks d.p.i., low titers of virus neutralizing antibody 
can be detected, but their role in protective immunity to PRRSV is controversial (50, 53, 54).  
While data are available that demonstrate a protective role for neutralizing antibodies in PRRSV 
infections (27, 50, 69), other studies have shown that viremia not only occurs in the presence of 
these antibodies (112), but that low titers might be associated with enhanced viral infection (a 
phenomenon termed antibody-dependent enhancement of infection, ADE) (116). 
A delayed T-cell response is also seen in PRRSV infections, and results in unusually 
weak Th1 cytokine secretion and high Th2 responses.  Generally, interferon gamma (IFNγ) 
secreting-cells and proliferative lymphocyte responses occur by 4-8 weeks p.i. (50, 115), but 
both the T-cell mediated immune response and antibody titers to PRRSV have been reported to 
decline over time while abundant viral antigen is still present in lymphoid tissues (63, 115).  
Thus a delay in certain functions of the humoral and cellular arms of the immune response may 
be involved in the inefficient viral clearance resulting in persistent infections.   
Cytokine Production 
Intracellular pathogens, such as viruses, are generally processed via major-
histocompatibility I (MHC I) pathways which utilize a proteosome to degrade cytosolic proteins 
into linear peptides, then display them in antigen binding grooves on MHC I proteins.  Cytotoxic 
T-lymphocytes (CTLs) are required for recognition of the foreign antigens displayed on MHC I 
proteins, and recognition stimulates an immune response appropriate for those antigens.  
Extracellular pathogens (e.g. bacteria and whole viruses) are broken down and processed via the 
major-histocompatibility complex MHC II pathway which utilizes specialized antigen-presenting 
cells to engulf and degrade the pathogens and present the components via the MHC II protein.  
Since several types of cells are involved in an active immune response, the host system uses 
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 cytokines to specifically activate the appropriate effector cells, which ensures that responses 
proceed along the correct processing pathway for efficient pathogen elimination (38). 
Current data suggest that a Th-2 mediated humoral immune response occurs during 
PRRSV infection, resulting in inefficient elimination of virus and potentially constituting 
persistent infections in viremic pigs (64, 107).  This hypothesis is supported by studies that show 
that interleukin-10 (IL-10), a Th2 cytokine that protects cells from apoptosis, is upregulated  in 
vivo in infected pigs (80, 91, 92, 98), and in vitro in infected cultured macrophages, monocytes 
and dendritic cells (35, 91).  Interestingly, the Th-1 associated cytokine, Interferon-γ (IFNγ), is 
also upregulated in response to PRRSV infection (32, 57, 62, 109), and although it has been 
shown to be involved in immune responses against PRRSV, its appearance is generally delayed 
(6, 84, 102). 
In contrast, studies to evaluate the involvement of other cytokines in the immune 
response to PRRSV have shown mixed results.  For example, weak upregulation of tumor-
necrosis factor-α (TNFα), an important Th1 cytokine, was documented in some studies (14, 37), 
while substantial TNFα induction was observed in others (13, 80).  Likewise, evidence of poor 
interferon-α (IFNα) induction compared to other porcine respiratory viruses exists for both in 
vivo and in vitro infections (3, 8, 61, 102), and correlates with reports that IFNα blocks PRRSV 
replication (55) but contrasts with an in vitro study that demonstrates that pre-treatment of 
monocytes with IFNα results in a strong increase in susceptibility to PRRSV-infection (30).  
Collectively, however, data suggest that PRRSV manipulates host cells to regulate production of 
cytokines which are involved in viral replication and transmission. 
Apoptosis 
Apoptosis is an innate defense mechanism that often functions to eliminate virally 
infected cells through tightly regulated induction of cell death.  Some viruses, however, regulate 
apoptosis in target cells as a means of facilitating viral propagation.  Recently, the predominance 
of transcripts involved in promoting cell survival has been demonstrated in PRRSV-infected 
PAM using microarray analysis (37).  This study showed an upregulation of anti-apoptotic 
transcripts and downregulation of pro-apoptotic genes during a 12 hour viral incubation, which 
corresponds with other studies that describe an initial upregulation of anti-apoptotic genes during 
the early stages of PRRSV infection and pro-apoptotic genes in later stages (47), and contributes 
to data suggesting that PRRSV actively manipulates apoptosis regulatory genes in order to 
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 complete its viral replication cycle. While several studies have demonstrated the induction of 
apoptosis by PRRSV in vivo and in vitro it is controversial whether the apoptosis is directly or 
indirectly associated with PRRSV infection (37, 47, 51, 61, 89).  Some data that suggest that 
PRRSV directly induces apoptosis in infected cells, while contrasting information indicates that 
apoptosis occurs in bystander, non-infected cells.   
Objectives of this study 
Factors determining cellular permissiveness or resistance to PRRSV infection remain 
largely uncharacterized.  A recent study from our laboratory (36) demonstrated that 1) 
permissiveness to PRRSV infection increased with time in culture, 2) cultured PAM from 
infected pigs could be superinfected, and 3) addition of actinomycin D, which inhibits mRNA 
synthesis, blocked infection.  Implications were that a PRRSV-permissive subpopulation of cells 
arises in culture from a non-permissive precursor population. The current study was designed to 
examine potential factors involved in susceptibility to PRRSV infection by investigating 
phenotypic differences between infected and non-infected PAM within a single population in 
vitro.   
CHAPTER 2 - Materials and Methods 
Cells and Virus 
PAM cells were obtained from 4-6 week old PRRSV-seronegative pigs (confirmed via 
ELISA) using 1L of sterile PBS to lavage lungs from each animal immediately following 
euthanasia.  Lavage fluid was collected by filling each set of lungs with PBS three times, gently 
massaging to help separate the cells from tissue between PBS aliquots, and pouring the solutions 
into 50 ml conical tubes.  Cells were subsequently washed two times in Dulbecco's modified 
eagles medium (DMEM) (Gibco), then frozen and stored in liquid nitrogen at 2 x 107 cells/vial in 
Opti-Freeze DMSO Cryopreservation Medium (Fisher).  Centrifugation was at 730 g for 5 
minutes unless otherwise noted.  PAM were incubated in a 37ºC water bath for approximately 
five minutes after removal from liquid nitrogen to rapidly thaw the cells, then were washed in 
RPMI-1640 medium (Cellgro) to remove the DMSO-containing freezing medium.  PAM were 
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 re-suspended in RPMI-1640 medium supplemented with 10% fetal bovine serum (FBS), 1% L-
glutamine, 1% fungizone and 1% penicillin/streptomycin, checked for viability using .04% 
trypan blue to stain a representative portion of the cells, then seeded on 12-well polystyrene 
tissue culture plates.  Medium was replaced after one hour of incubation at 37°C and 5% CO2 to 
remove non-adherent cells, then incubation was resumed.  Because PAM have been 
demonstrated to have increased permissiveness to PRRSV infection after a 24 hour culture 
period (34, 36), cells were infected after 24 hours of incubation using PRRSV isolate NVSL 97-
7895.  Cells were removed from the plastic cell culture plates using a plastic scraper after 18 hrs 
of incubation V- bottom plates (Starstedt) and individually incubated with specific monoclonal 
antibodies to surface proteins found on macrophage lineage cells, then with secondary, isotype 
specific antibodies.  Negative and secondary isotype controls were included for each experiment.  
After labeling, cells were fixed in 4% paraformaldehyde for a minimum of 30 minutes, then 
transferred PBS, pipetted into 5 ml polystyrene round-bottom falcon tubes (BD Biosciences) and 
analyzed by flow cytometry.      
PRRSV isolate NVSL 97-7895 was used in this study at a multiplicity of infection 
(m.o.i.) of approximately 0.1 TCID50 per cell.  Virus stocks were grown on confluent MARC-
145 cells in T-75 tissue culture flasks using minimal essential medium (MEM) (Gibco) + 7% 
FBS + 1% pen/strep + 1% fungizone and incubated at 37°C, in 5% CO2.  Virus stocks were 
prepared by collecting high-titer (106-8 TCID50 per ml) culture supernatants 48-72 hr post 
inoculation (p.i.) and freezing them in cryovials (Nalgene) at -80°C in until used.  Titrations were 
performed in triplicate on confluent MARC-145 cells using 1:10 serial dilutions, and m.o.i. was 
calculated as the ratio between the TCID50 value and the number of cells in culture  Cytopathic 
effect (CPE) was identified by the characteristic rounding and detachment of PAM and MARC-
145 from the culture plate surface as visualized by microscopic observation.  In addition to 
NVSL 97-7895, several other PRRS viruses were examined for their ability to infect PAM cells, 
including PR-GFP, VR2332, SD23983, 98-87, 06-625.22, two SD type 2 PRRSV strains (2672 
and 2367), and passages 13 and 29 of 97-7895 PRRSV isolates.     
Antibody Labeling 
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 PAMs were removed from tissue culture plates using plastic disposable scrapers and washed 
twice using cold first wash buffer (FWB; PBS + 10% ACD + 2% FBS + 1% phenol red + .4% 
sodium azide (at 20%)).  Surface marker expression was evaluated by individually incubating 
approximately 1 x 106 PAM with recommended concentration of monoclonal antibodies specific 
for the antigen of interest (see Table 1).  After incubation, cells were washed three times in FWB 
to remove unbound antibody, then incubated with R-Phycoerytherin- (RPE) conjugated 
secondary antibody (Caltag, Serotec) specific for the isotype of the primary antibody.  Cells were 
washed four times in second wash buffer (SWB; PBS + 10% ACD + 1% phenol red + .4% 
sodium azide (at 20%)), then fixed in 4% paraformaldehyde.  PRRSV-infected cells were 
detected using the Cytofix/Cytoperm™ Fixation/Permeabilization kit (BD Biosciences, protocol 
followed as directed) and a standard dilution of 1:100 fluorescein isothiocyanate (FITC)-
conjugated SDOW17 antibody specific to the PRRSV nucleocapsid protein.  SDOW17 antibody 
is reactive with a portion of the N-protein that is conserved between type 1 and type 2 PRRSV 
isolates, and was generously provided by Dr. Eric Nelson of South Dakota State University in 
Brookings (67).  After incubation with SDOW17 antibody, cells were washed four times, then 
were resuspended in PBS and analyzed using flow cytometry.    
Immunofluorescence Assay 
Medium was aspirated from PAM cultures 18 hours after viral inoculation.  The adherent cells 
were fixed in 80% acetone for ten minutes, and then were allowed to air dry.  PAMs were 
labeled using FITC-conjugated SDOW17 antibody, and the percentage of infected cells was 
determined using fluorescence microscopy.   
Measurement of Cytokine Production 
 Bacterial lipopolysaccharide (LPS) (Sigma-Aldrich) was used as a positive control to stimulate 
the classical activation pathway in PAM.  LPS was added to cultured PAM at 1 ug/ml when 
media was changed after one hour of incubation.  Intracellular cytokine proteins made in infected 
and control PAM were evaluated using the Cytofix/Cytoperm™ Fixation/Permeabilization kit 
with GolgiPlug™ containing the protein transport inhibitor brefeldin A (BD Biosciences).  In 
this assay, the addition of brefeldin A to cell cultures blocks intracellular transport, resulting in 
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 accumulation of cytokine proteins in the Golgi complex.  Cells were treated with GolgiPlug™ 12 
hours before collection.  PAM were removed from tissue culture plates using plastic disposable 
scrapers and permeablized.  Cytokines were labeled using monoclonal antibodies to TNFα, 
TGFβ1 and TGFβ2 (Santa Cruz Biotechnology) and FITC-conjugated secondary antibodies 
(Caltag), then analyzed by flow cytometry.  Controls for surface expression of the cytokines 
were included. 
 Apoptosis Assay  
Three different techniques were used to evaluate apoptosis in infected and control PAM.  The 
first assay utilized FITC-conjugated Annexin V (Serotec) to bind to membrane phospholipid 
phosphatidylserine (PS) which is exposed on the cell surface during the early stages of apoptosis 
(according to literature provided by the manufacturer), and was analyzed using flow cytometry. 
Detection of PS identifies cells entering apoptosis that have not yet undergone nuclear changes 
such as DNA fragmentation. For the second assay, proteolytic enzymes called caspases were 
assayed to identify cells between the early and late stages of apoptosis.  Caspases are a central 
component of apoptosis that participate in substrate cleavage, and were detected by binding of 
carboxyfluorescein labeled fluoromethyl ketone (FMK)-peptide inhibitors (Cell Technology 
Incorporated) to the activated caspases then analyzed using flow cytometry. The third technique 
examined cellular DNA for the fragmentation characteristic of late stages in apoptosis, using 
QIAamp® DNA Mini Kit (Qiagen) to isolate DNA, followed by agarose gel electrophoresis.  
Actinomycin-D (Ac-D) (EMD Biosciences), which at 500 ng/ml can induce apoptosis, was 
included as a positive control in each experiment.  In all assays, PAM were cultured for 24 hours 
as described above, infected and incubated an additional 18 hours, then collected by scraping. 
Ac-D was added to positive control wells after one hour incubation.   
Flow Cytometric Analysis 
After labeling, cells were stored at 4°C until analyzed.  Ten thousand cells from each control and 
antibody-labeled cell suspension were acquired using a FACSCalibur flow cytometer (BD 
Biosciences). Parameters used include forward scatter (FSC), side scatter (SSC), fluorescence 
one (FL1) (green) and fluorescence two (FL2) (orange-red).  Data was analyzed using CellQuest 
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 software (BD Biosciences) to calculate percentages of labeled cells and to evaluate fluorescence 
intensity in the PAM population.   
CHAPTER 3 - Results 
Selection of virus strain for use in study 
Because many PRRSV isolates are available for cell culture and in vivo work, this study was 
initiated by screening different isolates for their capacity to infect macrophages.  Ten existing 
PRRSV-stock viruses were tested.  The percentage of PRRSV-infected cells was determined 
using two different methods: flow cytometry and IFA.  The data, presented in Figure 1, showed 
that isolate 97-7895 (P13) of PRRSV infected the largest percentage of PAM in vitro.  However, 
because it is an isolate recently obtained from pigs, because the genome has been completely 
sequenced, and because it demonstrated a high percentage of infectivity for PAM in culture, we 
used PRRSV isolate NVSL 97-7895 for the remaining experiments.    
Regulation of PAM surface protein expression 
Surface Protein Expression in Fresh vs. Frozen PAM Cells 
The first experiments were designed to determine whether or not there were differences 
between freshly isolated and frozen PAMs, in order to confirm whether or not whether freezing 
had an effect on permissiveness for PRRSV and cell surface marker expression. Surface marker 
expression was examined by culturing fresh PAM and PAM from the same pig that had been 
frozen in liquid nitrogen for two months.  PAM were cultured for 24 hours then inoculated with 
PRRSV and re-incubated for an additional 18 hours.  Uninfected control cultures were included.  
Results indicated that fresh PAM cells were less permissive for PRRSV-infection than were 
frozen PAM, suggesting that the freezing process may result in development of a PRRSV-
permissive state in PAM (Figure 2).  Surface molecule phenotyping revealed that MHC II, 
CD14, CD163 and CD172a were not affected by freezing, but that MHC I was no longer 
detectable.  Dot plots illustrate these findings (Figure 3) and a bar graph summarizes the data 
from PAM taken from three animals (Figure 4). 
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 Differential protein expression in PRRSV-positive and PRRSV-negative cells  
In order to gain insight into the phenotypic characteristics of PRRSV-permissive PAM, 
MHC I, MHC II, CD14, CD163 and CD172a surface proteins on PRRSV-infected and non-
infected cells within the same PAM populations were evaluated.  There were no detectable 
differences in the percentage of cells expressing each surface molecule between PRRSV-infected 
uninfected controls.  However, when analyzed using mean fluorescence intensity (MFI), 
differences were seen between infected and non-infected PAM populations (Figure 5).  Mean 
fluorescence intensity was used to assess the relative number of surface molecules on 
approximately 90% of the gated population (Figure 6).  Mean fluorescence intensities for surface 
molecules on the PRRSV-infected and non-infected PAM in infected cultures were then 
compared to control PAM to determine whether or not PRRSV had an effect on surface protein 
expression in these subpopulations.  An overlaid histogram illustrates the upregulation of CD14 
in PRRSV-infected cells and downregulation in PRRSV-negative cells from the same culture 
when compared to control cell surface profiles (Figure 7).  Bar graphs representing data from 
PAM taken from 5 pigs depict the differences between PRRSV-permissive and non-permissive 
populations, and illustrate the differences in expression levels between the PAM taken from 
different animals (Figure 8).  Raw expression percentages are also shown (Table 1). 
Cytokines 
In order to characterize the activation pathway utilized by PRRSV infected PAM, we 
evaluated cytokine expression of PAM within control and LPS or PRRSV-stimulated cultures.  
Figure 9 depicts profiles of cytokine synthesis in PAM from infected and uninfected cultures.  
Using tumor necrosis factor α (TNFα) and tumor growth factor β (TGFβ) 1 and 2 to examine 
classical vs. alternative activation pathways, respectively, we labeled intracellular cytokines with 
fluorescently tagged antibodies and analyzed them using flow cytometry.   
Although cytokine responses to PRRSV and LPS were uniquely different relative to 
control PAM, no trends were detected in the responses of PAM infected with PRRSV compared 
to uninfected and classically stimulated PAM.  Figure 10 shows the cytokine production in the 
PAM cultures taken from pigs in this study.   Since time courses of cytokine synthesis were 
performed prior to these experiments, we were confident that the timing of collection was 
correct.  One possible explanation is that the levels of cytokines produced are too low to be 
12 
 detectable at a significant level using flow cytometry.  Because of the electronics systems of flow 
cytometers, a difference of five percent or greater is recommended before are considered 
statistically relevant, so that detection of cytokines that are produced in small amounts might be 
better accomplished using a more sensitive technique (e.g. PCR). 
Apoptosis 
To determine whether or not apoptosis occurred in the infected PAM cultures, we 
evaluated apoptosis in control, PRRSV- and Ac-D-treated PAM cultures.  Since apoptosis is a 
complex process, and PRRSV infection can result in atypical apoptosis (47), we used three 
detection techniques to address the issue.  Early apoptosis was evaluated using Annexin V.  The 
results indicated that, while all of the macrophages took up propidium iodide (PI), likely through 
pinocytosis, fewer than 1% of the PAM labeled for Annexin V, consistent with the idea that 
apoptosis had not occurred in the infected cells (Figure 11).  Caspase detection assays were used 
to evaluate middle apoptosis, and also show no detectable apoptosis in infected control cultures 
(Figure 12).  Finally, a DNA fragmentation assay was utilized to evaluate late apoptosis; no 
fragmentation was detected, suggesting that no cells were in the late stages of apoptosis (Figure 
13).   Thus, the PAM in PRRSV inoculated cultures do not appear to have been in apoptosis.  
However, it remains to be determined whether or not apoptosis has occurred in either the 
infected cells or the uninfected cells in the inoculated cultures. 
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Figures and Tables 
  
specificity clone 
name 
isotype source 
MHC I 2G5 IgG2b Serotec 
MHC II DQ K274.3G8 IgG1 Serotec 
CD14 MIL-2 IgG2b Serotec 
CD163 2A100/11 IgG1 Serotec 
CD172a 74-22-15A IgG2b VMRD 
TNFα MAb11 IgG1 Santa Cruz 
Biotechnology 
TGFβ1 C-16 IgG Santa Cruz 
Biotechnology 
TGFβ2 Zg-12 IgG2b Santa Cruz 
Biotechnology 
Table 1: Monoclonal antibodies used in these studies 
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Figure 1: Virus Selection.  Virus comparisons were performed by flow cytometric assessment 
of the percentage of infected cells resulting form inoculation with each isolate. Each bar 
represents results from a single culture and the virus isolates are named at the bottom of the 
graph.  
 
 
 
 
 % of Infected Cells 
SDOW17 
Control 3.3 
PR-GFP 13.6 
SD Type 2 
(2672) 7 
SD Type 2 
(2367) 3.6 
97-7895 (P29) 2.6 
97-7895 (P13) 14.3 
06-625.22 7.6 
VR2332 6.3 
SD23983 4 
98-87 11.6 
NVSL 97-7895 8.3 
 
Table 2: IFA results for virus selection.  Virus comparisons were performed by 
immunofluorescence of PAM detected using a fluorescence microscope.  Values are slightly 
higher than those in Figure 1, likely due to differences in equipment sensitivity.   
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Figure 2: Fresh vs. Frozen PAM Infectability.  PAM susceptibility to PRRSV infection 
after freezing was determined by flow cytometric analysis of the percentage of infected 
cells resulting from inoculation of either fresh PAM or those that had been frozen. PRRSV 
permissiveness in PAM from two animals is depicted, and each bar represents results from 
a single culture. 
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Figure 3: Dot plots illustrating surface protein expression levels in fresh and 
frozen PAM.  Surface antigen comparisons were performed by flow cytometric 
assessment of the percentage of cells expressing individual surface proteins in fresh 
and frozen PAM from the same animal (given in upper right of each dot plot).  Dot 
plots represent results from a single culture.  A-E = fresh PAM cultures, F-L = frozen 
PAM cultures. Panels A and F depict MHC I expression levels, panels B and G depict 
MHC II expression levels, panels C and H depict CD14 levels, panels D and I depict 
CD163 expression levels, and panels E and J depict CD172a levels.   
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Figure 4: Surface Protein Expression in Fresh and Frozen PAM.  Bar graph representation of the data in 
Figure 3 demonstrates comparable levels of most surface antigens after PAM were frozen.  Each bar represents 
a single surface protein, and three different animals’ PAM are shown.  Surface molecule name and animal 
number are listed at the bottom of the graph.   
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Figure 5: Representative histograms show a difference in CD14 expression levels, while 
dot plots demonstrated no change.  Surface protein expression comparisons were performed 
by flow cytometric assessment of PRRSV infected and control PAM.  A-B depict the 
percentage of infected cells expressing CD14 using dot plots, and C-E depict the level of CD14 
expressed on 90% of the PAM in our population of interest using histograms.  Percentage of 
surface protein expression and MFI are expressed with each figure.  Panel A depicts CD14 
expression on uninfected control PAM, and panel B depicts CD14 expression on PRRSV 
infected PAM.  Panel C depicts MFI for CD14 expression in uninoculated control cultures, 
panel D depicts MFI for CD14 expression in PRRSV negative PAM, and panel E depicts MFI 
for CD14 expression in PRRSV positive PAM.   
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Figure 6: Representative histograms comparing mean fluorescence in PRRSV-positive and 
negative cells compared to control populations.  Surface molecule expression levels on PRRSV 
infected and uninfected PAM within a single culture are compared to uninoculated control PAM using 
flow cytometric analysis and histogram representation.  Panels A and B depict the cell population of 
interest, C-G are uninoculated control PAM, H-L depict PRRSV negative PAM within a PRRSV 
inoculated culture and M-Q depict PRRSV positive PAM.  Panels C, H and M depict MHC I expression, 
panels D, I and N depict MHC II expression, panels E, J and O depict CD14 expression, panels F, K and 
P depict CD163 expression, and panels G, L and Q depict CD172a expression.  The percentage of surface 
protein expression and MFI are expressed with each figure. 
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Figure 7:  Overlaid CD14 histograms illustrate mean fluorescence intensity differences.  A histogram 
overlay depicts differences in expression levels of CD14 between PRRSV infected and uninfected PAM 
compared to uninoculated control PAM.  Each overlay is labeled with the population it represents and the MFI 
in the histogram above.   
 
23 
 Pig #/treatment Cell Surface Molecule (MFI) 
 MHC I MHC II CD14 CD163 SWC3a
P6 PAMa 1.87 42.72 7.7 56.18 93.23 
P6 PAM Negb 1.8 40.41 6.89 55.85 78.48 
P6 PAM Posc 3.08 67.43 14.46 148.29 128.42 
P7 PAM 1.74 45.43 216.44 37.97 132.22 
P7 PAM Neg 1.51 37.92 145.78 30.37 87.65 
P7 PAM Pos 2.09 58.15 424.75 49.96 222.7 
P8 PAM 1.71 194.51 274.26 54.65 515.14 
P8 PAM Neg 1.59 166.61 158.97 43.98 363.22 
P8 PAM Pos 2.5 255.12 487.44 80.33 607.34 
P10 PAMa 1.29 80.37 65.59 29 163.55 
P10 PAM Neg 1.26 70.06 47.1 21.65 137.88 
P10 PAM Pos 2.35 125.39 121.42 40.92 225.9 
P11 PAMa 1.89 137.13 121.05 101.54 291.5 
P11 PAM Neg 1.96 118.95 83.37 84.54 202.67 
P11 PAM Pos 4.12 379.2 291.37 139.41 315.61 
Table 3: Raw data showing differences in expression levels of surface proteins.  Data from 
Figure 6 is presented in table form.  a = control PAM, b = PRRSV negative PAM and c = 
PRRSV positive PAM.  Antibody control range was .23-1.89% 
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Figure 8: Bar graph representations of surface protein expression levels in five 
different animals.  Surface molecule expression levels were examined for five different animals 
as described in Figure 6.  Data is presented in bar graph form to depict differences between PAM 
treatment groups as well as expression levels in individual animals. The molecule of interest is 
labeled above each graph, as are animal ID’s.  Treatments for each animal include control PAM 
(labeled as plain animal ID), non-infected PAM within PRRSV-inoculated cultures (labeled as 
animal ID o/v), and infected PAM from the same culture (labeled as animal ID V). 
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Figure 9: Representative dot plots illustrating cytokine production in infected and 
control PAM.  Cytokine production was assessed using flow cytometry to identify 
their presence and relative concentrations in PRRSV infected, uninfected, and LPS 
control PAM.  Each dot plot represents an individual culture.  Panels A and B depict 
the cell population of interest, panels C, D and E represent IgG1, IgG, and IgG2b 
secondary antibody controls, respectably.  Panels F, G and H depict TNFα within the 
cells, and panels F, J and K depict TNFα on the surface of PAM.  Panels L, M and N 
depict TGFβ1 within the cells, and panels O, P and Q depict TGFβ1 on the surface of 
PAM cells.  Panels R, S and T depict TGFβ2 within the cells, and panels U, V and W 
depict TGFβ2 on the surface of PAM.  Percentage of PAM expressing each and 
treatment descriptions are provided with each dot plot.   
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Figure 10: Representative bar graphs showing no trend in expression.  Intracellular cytokine levels were 
examined for three different animals as described in Figure 9.  Data is presented in bar graph form to depict 
differences between PAM treatment groups as well as expression levels in individual animals. The cytokine of 
interest is labeled above each graph, as are animal ID’s.  Each bar represents a single culture and treatment 
descriptions are provided at the bottom of each graph.   
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Figure 11: Representative dot plots demonstrating apoptosis levels in PRRSV-inoculated and control 
cultures using Annexin V.  PAM in early apoptosis were examined using flow cytometry.  Panels A and B 
depict the population of interest.  Panel C depicts negative control PAM, panel D depicts PRRSV infected 
PAM, and panel D depicts Ac-D treated control PAM.  The percentage of PAM in each quadrant are given 
with each dot plot.   
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Figure 12: Representative dot plots demonstrating apoptosis levels in PRRSV-inoculated and control 
cultures by detection of caspases.  PAM undergoing apoptosis were examined using flow cytometry.  Panels 
A and B depict the population of interest.  Panel C depicts negative control PAM, panel D depicts PRRSV 
infected PAM, and panel D depicts Ac-D treated control PAM.  The percentage of PAM in each quadrant are 
given with each dot plot.   
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Figure 13: Gel demonstrates the absence of fragmented DNA in infected and control PAM.  PAM in late 
apoptosis were examined by looking for DNA fragmentation.  10 ul of DNA was added to each lane on a 1% 
agarose gel and ran for approximately 45 minutes at 110v.  For each pig, the first lane contains DNA from 
control PAM, the second lane contains DNA from PRRSV infected PAM and the third lane contains Ac-D 
control PAM DNA.  Lane 1 is the DNA ladder, lanes 2-4 contain DNA from pig #1 PAM, 5-7 contain DNA 
from pig #2 PAM, and lanes 8-10 contain DNA from pig #9 PAM.   
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CHAPTER 4 - Discussion 
Cells of the monocoyte/macrophage lineage express several surface proteins that are 
involved in their functions.  Among them are MHC I, MHC II, CD14, CD163, and CD172a.  The 
data consistently demonstrated upregulation of MHC II, CD14, CD163 and CD172a expression 
in PRRSV-infected cells and downregulation on the uninfected cells within the PRRSV-
inoculated cultures when compared to control cultures.  This observation is consistent with 
another study in which CD14 upregulation was demonstrated in PRRSV-inoculated cultures 
(100).  Our results suggest that there are at least two subsets of macrophages within the alveolar 
population, one of which is PRRSV susceptible, and that the subsets have differentially regulated 
surface molecule expression.  Upregulation on infected PAM of molecules involved in 
macrophage functions suggests that PRRSV manipulates the antigen detection and presentation 
capabilities of these cells.  MHC I was also examined, however the expression was reduced 
below detectable levels after the PAM had been stored in liquid nitrogen. 
Interestingly, we also demonstrated that PRRSV permissiveness appears to have been 
induced in an additional portion of the cell population by the freezing process.  One possible 
explanation for this observation is that other cells found in lung lavage are lost during 
freezing/thawing of the cell suspensions, either PRRSV-nonpermissive PAM or another cell type 
which secretes anti-viral factors.  Since PAM are thought to require a specific state of activation 
or differentiation to be permissive for infection (34), another possible explanation is that freezing 
results in induction of a PRRSV-susceptible state in a subset of PAM.  Finally, the observation 
that PAM appear to lose MHC I expression after freezing, in conjunction with increasing 
permissiveness for infection by PRRSV, suggests that a currently unidentified association exists 
between MHC I expression and permissiveness of PAM to PRRSV.  Work supporting this idea 
has shown MHC I downregulation in PRRSV-infected PAM, PBMC and mo-DC (93, 107).   
Because surface protein expression was altered, we sought to determine how the infection 
might induce such changes.  Thus, we evaluated alternative activation and apoptosis as possible 
explanations for the surface expression changes observed in the infected cultures.  Alternative 
activation of PAM could explain an abnormal host response to PRRSV.  Classically activated 
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 macrophages exhibit a Th1-like cytokine profile, secreting TNFα and IL-13 which promote 
inflammation and apoptosis, while alternatively activated macrophages display a Th2-like 
phenotype, promoting cell proliferation and angiogenesis, and resolving inflammation.  Indeed, 
the upregulation of CD163 on infected PAM is consistent with the idea of an anti-inflammatory 
profile for these cells (9).  We sought to determine whether PRRSV-infected macrophages were 
classically or alternatively activated by examining TNFα and TGFβ production in PRRSV-
infected, LPS- and non-treated control cells.  However, no trend could be detected, suggesting 
that PRRSV does not alter the activation status of PAM.  
Apoptosis induction is also a mechanisms by which PRRSV might control PAM.  Since 
apoptosis occurs in stages, we examined cells for early, middle, and late apoptosis.  However, 
apoptosis was not detectable in infected cultures.  Apoptosis has been demonstrated to exhibit 
late onset (3 d.p.i.) during PRRSV infection of MARC-145 cells (47).  This, combined with data 
showing no apoptosis after 12 hr p.i. in PAM (37) and our 18 hour time course, may account for 
our observations that PRRSV infected cells do not appear to differ from non-infected controls in 
the detection of cells in any stage of apoptosis.  In addition, our studies compared PRRSV-
inoculated and un-inoculated cultures, and it is possible that the apoptotic population is too small 
for differences to be noticeable without separating the populations for examination.  Future 
experiments are required to investigate the issue further. 
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